Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.025
-0.025 (-1.22%)
Jul 6, 2026, 4:24 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 11.47 million as of July 6, 2026. Its market cap has increased by 226.31% in one year.
Market Cap
11.47M
Enterprise Value
11.36M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.03
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 11.47M, a decrease of -65.90%. That is a compound annual growth rate of -21.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 11.47M | 25.62% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 27.21M |
| Arecor Therapeutics | 23.98M |
| ImmuPharma | 21.68M |
| IXICO | 17.99M |
| Aptamer Group | 16.41M |
| Fusion Antibodies | 15.00M |
| Palatin Technologies | 14.43M |
| Cizzle Biotechnology Holdings | 10.62M |